CompletedPHASE2, PHASE3NCT01464242

Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centro Internacional de Entrenamiento e Investigaciones Médicas
Principal Investigator
Nancy C Saravia, PhD
Centro Internacional de Entrenamiento e Investigación Médica
Intervention
Meglumine antimonate(drug)
Enrollment
75 enrolled
Eligibility
18-65 years · All sexes
Timeline
2011 – 2015

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01464242 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials